Viewing Study NCT06304857


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2026-02-02 @ 7:38 AM
Study NCT ID: NCT06304857
Status: RECRUITING
Last Update Posted: 2024-12-04
First Post: 2023-10-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None heart failure View
None ejection fraction View
None anthracyclines View